Operator-turned-venture investor with experience sourcing and scaling early-stage technology companies, focused on fintech, consumer platforms and climate-tech. Maggie Hartness combines operating leadership, board experience and sector-focused investing to evaluate product-market fit, unit economics and growth capital needs. Known for hands-on portfolio support, strategic go-to-market counsel and follow-on capital mobilization; frequently advises founders on metrics-driven scaling and capital strategy.
Operator-turned-venture investor with experience sourcing and scaling early-stage technology companies, focused on fintech, consumer platforms and climate-tech. Maggie Hartness combines operating leadership, board experience and sector-focused investing to evaluate product-market fit, unit economics and growth capital needs. Known for hands-on portfolio support, strategic go-to-market counsel and follow-on capital mobilization; frequently advises founders on metrics-driven scaling and capital strategy.
Operator-turned-venture investor with experience sourcing and scaling early-stage technology companies, focused on fintech, consumer platforms and climate-tech. Maggie Hartness combines operating leadership, board experience and sector-focused investing to evaluate product-market fit, unit economics and growth capital needs. Known for hands-on portfolio support, strategic go-to-market counsel and follow-on capital mobilization; frequently advises founders on metrics-driven scaling and capital strategy.
Operator-turned-venture investor with experience sourcing and scaling early-stage technology companies, focused on fintech, consumer platforms and climate-tech. Maggie Hartness combines operating leadership, board experience and sector-focused investing to evaluate product-market fit, unit economics and growth capital needs. Known for hands-on portfolio support, strategic go-to-market counsel and follow-on capital mobilization; frequently advises founders on metrics-driven scaling and capital strategy.
| Trades 1696 | Longs Won 1218/1696 71% | Profit Factor 9.55 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $803,424.3 |
| Average Win $190,631.23 | Best Trade (Oct 15) $18.08M | Sharpe Ratio -13.92 |
| Average Loss -$50,882.37 | Worst Trade (Jun 29) -$1.23M | Z-Score 0.6 (44.91%) |
| Commissions $0 | Avg. Trade Length 2y 4m 1w 2d | Expectancy $122,563.13 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,130 | 7,317 | 6,504 | 5,691 | 4,878 | 4,065 | 3,252 | 2,439 | 1,626 | 813 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 109,796 | $24.9M | $37.63M | - | $12.73M | 51.12% | -0.076% |
ABBV AbbVie Inc. | 1,014 | $236,103.23 | $288,112.89 | - | $52,009.66 | 22.03% | +0.231% |
ABT Abbott Laboratories | 19,655 | $1.88M | $2.06M | - | $178,654.79 | 9.5% | +1.787% |
ADI Analog Devices, Inc. | 708 | $225,243 | $286,860.36 | - | $61,617.36 | 27.36% | +0.396% |
AJG Arthur J. Gallagher & Co. | 10,541 | $1.44M | $2.64M | - | $1.21M | 83.96% | +5.809% |
AMAT Applied Materials, Inc. | 2,464 | $1.78M | $1.06M | - | -$717,726.24 | -40.29% | -3.339% |
AMD Advanced Micro Devices, Inc. | 1,490 | $865,556 | $843,235.7 | - | -$22,320.3 | -2.58% | -0.857% |
AME Ametek Inc. | 950 | $180,444.61 | $236,379 | - | $55,934.39 | 31% | +0.806% |
AMGN Amgen Inc. | 1,969 | $523,207.59 | $859,960.75 | - | $336,753.16 | 64.36% | +2.497% |
AMZN Amazon.com Inc | 28,616 | $5.71M | $7.3M | - | $1.59M | 27.87% | +0.403% |
AVDE Avantis International Equity ETF | 71,796 | $6.12M | $6.45M | - | $335,956.19 | 5.49% | +0.711% |
AVDV Avantis International Small Cap Value ETF | 37,372 | $3.75M | $4.01M | - | $259,267.1 | 6.91% | +0.023% |
AVGO Broadcom Inc. | 8,734 | $942,403.7 | $3.01M | - | $2.07M | 219.29% | -0.5% |
AVY Avery Dennison Corporation | 2,240 | $228,189.06 | $393,422.4 | - | $165,233.34 | 72.41% | +2.208% |
AZN AstraZeneca PLC American Depositary Shares | 1,623 | $307,753 | $271,398.06 | - | -$36,354.94 | -11.81% | +3.203% |
BAC Bank of America Corporation | 59,162 | $1.99M | $3.06M | - | $1.06M | 53.36% | +0.564% |
BKR Baker Hughes Company | 6,484 | $391,086 | $349,682.12 | - | -$41,403.88 | -10.59% | -2.601% |
BLK BlackRock, Inc. | 605 | $572,758.32 | $677,128.1 | - | $104,369.78 | 18.22% | +4.231% |
BRK-B Berkshire Hathaway Inc. | 668 | $339,643.58 | $351,828.92 | - | $12,185.34 | 3.59% | +0.065% |
BSCR Invesco BulletShares 2027 Corporate Bond ETF | 18,058 | $355,728.91 | $353,846.51 | - | -$1,882.4 | -0.53% | +0.051% |